Pacing Characteristics of a Conventional Bipolar
Condition: Symptomatic Bradycardia Intervention: Device: Solia S lead with any BIOTRONIK Pacemaker Sponsor: Chun Chieh Wang Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Observation of Clozapine Treatment Safety in Bipolar Disorder.
Condition: Bipolar Disorder Intervention: Drug: Clozapine Sponsor: Medical University of Gdansk Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Pacing Characteristics of a Conventional Bipolar
Condition: Symptomatic Bradycardia Intervention: Device: Solia S lead with any BIOTRONIK Pacemaker Sponsor: Chun Chieh Wang Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Observation of Clozapine Treatment Safety in Bipolar Disorder.
Condition: Bipolar Disorder Intervention: Drug: Clozapine Sponsor: Medical University of Gdansk Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Pacing Characteristics of a Conventional Bipolar
Condition: Symptomatic Bradycardia Intervention: Device: Solia S lead with any BIOTRONIK Pacemaker Sponsor: Chun Chieh Wang Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Observation of Clozapine Treatment Safety in Bipolar Disorder.
Condition: Bipolar Disorder Intervention: Drug: Clozapine Sponsor: Medical University of Gdansk Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
Pacing Characteristics of a Conventional Bipolar
Condition: Symptomatic Bradycardia Intervention: Device: Solia S lead with any BIOTRONIK Pacemaker Sponsor: Chun Chieh Wang Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2023 Category: Research Source Type: clinical trials
NMDA Receptor Modulation for the Treatment of Bipolar I Disorder
Condition: Bipolar I Disorder Interventions: Drug: NMDAE; Drug: Placebo Cap Sponsors: China Medical University Hospital; National Science and Technology Council Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials
